319 related articles for article (PubMed ID: 30411484)
1. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
[TBL] [Abstract][Full Text] [Related]
2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
Hashimoto K
Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
[TBL] [Abstract][Full Text] [Related]
6. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
8. The Translational Potential of Non-coding RNAs and Multimodal MRI Data Sets as Diagnostic and Differential Diagnostic Biomarkers for Mood Disorders.
Todeva-Radneva A; Aryutova K; Kandilarova S; Paunova R; Stoyanov D
Curr Top Med Chem; 2021; 21(11):949-963. PubMed ID: 34355686
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
10. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
11. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
Ribeiro HC; Zandonadi FDS; Sussulini A
Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
[TBL] [Abstract][Full Text] [Related]
12. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
[TBL] [Abstract][Full Text] [Related]
14. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
15. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters.
Rive MM; Redlich R; Schmaal L; Marquand AF; Dannlowski U; Grotegerd D; Veltman DJ; Schene AH; Ruhé HG
Bipolar Disord; 2016 Nov; 18(7):612-623. PubMed ID: 27870505
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic analysis to detect urinary molecular changes associated with bipolar depression.
Ren Y; Chen ZZ; Sun XL; Duan HJ; Tian JS; Wang JY; Yang H
Neurosci Lett; 2021 Jan; 742():135515. PubMed ID: 33227370
[TBL] [Abstract][Full Text] [Related]
18. Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.
Sethi S; Hayashi MA; Sussulini A; Tasic L; Brietzke E
World J Biol Psychiatry; 2017 Oct; 18(7):506-520. PubMed ID: 26555297
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder.
Du Y; Dong JH; Chen L; Liu H; Zheng GE; Chen GY; Cheng Y
Oxid Med Cell Longev; 2022; 2022():5717445. PubMed ID: 35047107
[TBL] [Abstract][Full Text] [Related]
20. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
